Insufficient scRNA-seq data for expression of CHRNA5 at single-cell level.
Insufficient scRNA-seq data for expression of CHRNA5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 82.41 | 965 / 966 | 86% | 2.37 | 452 / 527 |
bladder | 100% | 39.76 | 21 / 21 | 84% | 2.54 | 423 / 504 |
esophagus | 96% | 33.63 | 1391 / 1445 | 85% | 2.77 | 156 / 183 |
stomach | 89% | 28.96 | 321 / 359 | 86% | 2.30 | 247 / 286 |
uterus | 98% | 39.12 | 166 / 170 | 75% | 2.16 | 346 / 459 |
pancreas | 98% | 30.11 | 322 / 328 | 72% | 2.11 | 129 / 178 |
prostate | 95% | 42.11 | 233 / 245 | 67% | 1.77 | 334 / 502 |
adrenal gland | 86% | 43.89 | 221 / 258 | 72% | 11.01 | 166 / 230 |
skin | 89% | 31.11 | 1609 / 1809 | 53% | 1.16 | 252 / 472 |
lung | 74% | 16.83 | 427 / 578 | 63% | 1.88 | 731 / 1155 |
ovary | 87% | 21.29 | 156 / 180 | 46% | 1.08 | 197 / 430 |
breast | 89% | 22.32 | 410 / 459 | 33% | 0.88 | 365 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.31 | 1 / 1 |
brain | 87% | 23.96 | 2301 / 2642 | 12% | 0.20 | 82 / 705 |
muscle | 93% | 35.70 | 749 / 803 | 0% | 0 | 0 / 0 |
heart | 87% | 25.19 | 751 / 861 | 0% | 0 | 0 / 0 |
adipose | 83% | 20.50 | 998 / 1204 | 0% | 0 | 0 / 0 |
thymus | 63% | 10.79 | 409 / 653 | 11% | 0.25 | 64 / 605 |
spleen | 64% | 8.83 | 155 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 62% | 10.50 | 827 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.19 | 23 / 45 |
kidney | 45% | 7.51 | 40 / 89 | 6% | 0.12 | 51 / 901 |
lymph node | 0% | 0 | 0 / 0 | 41% | 0.75 | 12 / 29 |
peripheral blood | 38% | 43.97 | 355 / 929 | 0% | 0 | 0 / 0 |
liver | 27% | 3.14 | 61 / 226 | 6% | 0.14 | 26 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051899 | Biological process | membrane depolarization |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007165 | Biological process | signal transduction |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
GO_0035095 | Biological process | behavioral response to nicotine |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0035094 | Biological process | response to nicotine |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0098691 | Cellular component | dopaminergic synapse |
GO_0043005 | Cellular component | neuron projection |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005892 | Cellular component | acetylcholine-gated channel complex |
GO_0015464 | Molecular function | acetylcholine receptor activity |
GO_0015276 | Molecular function | ligand-gated monoatomic ion channel activity |
GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHRNA5 |
Protein name | Neuronal nicotinic acetylcholine receptor, alpha5 subunit Neuronal acetylcholine receptor subunit alpha-5 Cholinergic receptor nicotinic alpha 5 subunit (Cholinergic receptor, nicotinic, alpha 5, isoform CRA_b) Cholinergic receptor nicotinic alpha 5 subunit |
Synonyms | NACHRA5 hCG_95858 |
Description | FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . |
Accessions | ENST00000559554.5 P30532 Q6EWN4 ENST00000394802.4 H0YM98 H0YK34 ENST00000559576.1 ENST00000299565.9 H7BYM0 |